PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
32740481-1	2020	OBJECTIVE: To examine responder rates and vasomotor symptom-free days with oral 17beta-estradiol/progesterone (E2/P4; TX-001HR) versus placebo in the REPLENISH trial.	Estradiol	80-96	cystatin 12, pseudogene	Homo sapiens	111-116